Alternate Day Buprenorphine Administration, Phase IX - 14
about
Alternate Day Buprenorphine Administration, Phase IX - 14
description
clinical trial
@en
klinisch onderzoek
@nl
name
Alternate Day Buprenorphine Administration, Phase IX - 14
@en
type
label
Alternate Day Buprenorphine Administration, Phase IX - 14
@en
prefLabel
Alternate Day Buprenorphine Administration, Phase IX - 14
@en
P1476
Alternate Day Buprenorphine Administration, Phase IX
@en
P3098
NCT00000232
P4844
P580
1992-03-01T00:00:00Z